title: Expansion of cancer care and control in countries of low and middle income: a call to action.
abstract: Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.
authors: Harvard Medical School, Boston, MA, USA.
authors: Paul
authors: P
authors: Farmer
authors: Julio
authors: J
authors: Frenk
authors: Felicia M
authors: FM
authors: Knaul
authors: Lawrence N
authors: LN
authors: Shulman
authors: George
authors: G
authors: Alleyne
authors: Lance
authors: L
authors: Armstrong
authors: Rifat
authors: R
authors: Atun
authors: Douglas
authors: D
authors: Blayney
authors: Lincoln
authors: L
authors: Chen
authors: Richard
authors: R
authors: Feachem
authors: Mary
authors: M
authors: Gospodarowicz
authors: Julie
authors: J
authors: Gralow
authors: Sanjay
authors: S
authors: Gupta
authors: Ana
authors: A
authors: Langer
authors: Julian
authors: J
authors: Lob-Levyt
authors: Claire
authors: C
authors: Neal
authors: Anthony
authors: A
authors: Mbewu
authors: Dina
authors: D
authors: Mired
authors: Peter
authors: P
authors: Piot
authors: K Srinath
authors: KS
authors: Reddy
authors: Jeffrey D
authors: JD
authors: Sachs
authors: Mahmoud
authors: M
authors: Sarhan
authors: John R
authors: JR
authors: Seffrin
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D003105:Colombia; D003906:Developing Countries / Q000191:economics*; D055088:Early Detection of Cancer; D014943:Global Health; D006205:Haiti; D006291:Health Policy; D006297:Health Services Accessibility / Q000191:economics* / Q000592:standards / Q000639:trends; D006301:Health Services Needs and Demand; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D015994:Incidence; D007182:Income; D019458:Insurance Coverage; D007348:Insurance, Health; D007597:Jordan; D008295:Malawi; D008403:Mass Screening; D008800:Mexico; D009369:Neoplasms / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D053918:Papillomavirus Vaccines / Q000008:administration & dosage; D011203:Poverty; D011634:Public Health; D012307:Risk Factors; D012432:Rwanda; D016540:Smoking Cessation; D012959:Socioeconomic Factors
chemical_list: D000970:Antineoplastic Agents; D017325:Hepatitis B Vaccines; D053918:Papillomavirus Vaccines